Exagen
在场
Exagen 是一家在股票代码 XGN (US) 下上市的公司。
高管
查看带有其 13 名主要高管的组织结构图
Exagen 搜索最多的简介
- John Aballi, Chief Executive Officer and President
- Scott Kahn, Director
- Tina Nova, Executive Chairman of the Board
高管在Exagen变化
- John Wegener 曾任 Senior Vice President of Sales and Marketing, 现升职为 Vice President, Sales (新闻发布的2024十二月5号).
- Jeffrey BlackJeffrey Black 将于20249月1作为 Chief Financial Officer 加入公司 (新闻发布的2024八月2号).
创建提醒
跟踪 Exagen 的高管变动
生物技术
Exagen 拥有 2,337 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
- OraSure Technologies has announced the acquisition of Sherlock Biosciences (公布2024十二月20号).
- SiteOne Therapeutics 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
Exagen 的最新新闻稿
- Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference | Exagen
- Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022 | Exagen
- Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility | Exagen
- Exagen Inc. Expands Coverage with MediNcrease | Exagen
- Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference | Exagen
- Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus | Exagen
- Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test | Exagen
- Exagen Inc. Reports First Quarter 2022 Results | Exagen
- Press Releases | Exagen
- Press Releases | Exagen
- View more press releases Close
通过电子邮件
